InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,487.03
(
0.25%
)
US TECH 100
19,430.40
(
0.14%
)
Dow Jones
38,834.86
(
0.15%
)
Brent Oil
84.90
(
0.13%
)
Bitcoin
65,053.20
(
-0.13%
)
Post# of 252254
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: mcbio post# 123977

Wednesday, 07/27/2011 5:57:40 AM

Wednesday, July 27, 2011 5:57:40 AM

Post# of 252254
Teva has 9.6% in Bioline and is the biggest among the controlling shareholders. Teva's strong man - Dr. Schwartz is the Chairman of the BOD and is quite active. On valuation: in general, local market usually gives low valuation to biotech comp. MC was a lot higher before Bioline announced partnering BL-1020. Investors here were very disappointed and the elevated risk plus the need to raise more cash is holding the stock.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up